Trial Citryl - Hidradenitis Suppurativa

Study ID: ORKA-002-214 for Hidradenitis Suppurativa

Summary

Study Details

Study Name	Age Requirements	Length of Study	Type of Treatment
ORKA-002-214	18 – 79 Years of age	Up to approximately 92 weeks	Subcutaneous injection

Adult’s Hidradenitis Suppurativa Study

Who Can Participate?

Adults aged 18 -79

Inclusion Criteria

Signs and symptoms for at least 6 months
At least 5 total abscesses and inflammatory nodules, with lesions in at least 2 distinct anatomic areas and at least 1 area at Hurley Stage II or III
Inadequate response, symptom recurrence after discontinuation, intolerance, or a contraindication to systemic antibiotics for HS

Participant Information

Participate and receive study treatment at no cost
Screening 1 to 4 weeks
16 weeks, randomized 1:1 and double-blind; ORKA-002 320 mg or placebo
Maintenance Up to 32 weeks, open-label ORKA-002
Follow-up 48 weeks afterthe final study-treatment dose
Administration Subcutaneous injection

How Long Will The Study Last?

Total participation Up to approximately 92 weeks

Contact us about joining the trial

To be eligible for this trial, applicants MUST have a skin condition. We DO NOT accept volunteers who do not have a skin disease.

Fill out this form to get in touch or call our clinical trial line at #(289)-763-8666. We will contact you in 1-2 business days regarding your application to participate in the trial.

First Name

Last Name

Phone Number

Email Address

Postal Code

Sex

Best Time to Reach You

Best Contact Method

Check this box to confirm you meet the study requirements, and consent to: recieving text notifications/emails about the trial, and (1) sharing your information with the study site, and (2) our Privacy Policy (see below). All provided information is confidential and will not be shared without your consent.

Privacy Policy for SimcoDerm Clinical Trials

Your privacy is important to us, and we take the protection of your personal health information (PHI) seriously. This policy explains how we collect, use, and protect your information.

We collect information directly from you, including your name, contact details, health information, and treatment history.

We use your information to determine eligibility for clinical trials, manage appointments, and communicate with you about your participation in clinical trials.

Data Protection:

Your information is stored securely and is only accessible by authorized personnel. We use data encryption, conduct security audits, and implement strict access controls to ensure the protection of your personal information.

You have the right to access, amend, or request the deletion of your health records. To exercise these rights, send a request to our clinical trial support team.